Metraipolis › archive › dc_f430acb59f22

Successful Treatment of Palmoplantar Psoriasis With Bimekizumab Following Secondary Loss of Response to Brodalumab: A Case Report — Europe PMC PMID:42801085

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42801085
DOI
10.7759/cureus.115287
License (as archived)
solo-consultazione
Archived
2026-10-08T12:10:39.132Z
SHA-256 of the archived text
2ecb082c73cbe59fbbdbca5f519487029cc23bdcdf14d6596c13bc5ae1ea6e6c
Stable URL of this page
https://metraipolis.com/documento/dc_f430acb59f22

How to cite

Successful Treatment of Palmoplantar Psoriasis With Bimekizumab Following Secondary Loss of Response to Brodalumab: A Case Report — Europe PMC PMID:42801085 — Europe PMC (en), https://europepmc.org/article/MED/42801085 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f430acb59f22 (Metraipolis archive dc_f430acb59f22, sha256 2ecb082c73cbe59fbbdbca5f519487029cc23bdcdf14d6596c13bc5ae1ea6e6c)
BibTeX
@misc{dcf430acb59f22,
  title = {Successful Treatment of Palmoplantar Psoriasis With Bimekizumab Following Secondary Loss of Response to Brodalumab: A Case Report — Europe PMC PMID:42801085},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42801085},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f430acb59f22; sha256 2ecb082c73cbe59fbbdbca5f519487029cc23bdcdf14d6596c13bc5ae1ea6e6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42801085. Agents can read the archived copy with the MCP tool read_document.